168541-96-6

Basic information

• Product Name: N-(cyanomethyl)-3-(4-fluorobenzoyl)-N-methyl-2-pyridinecarboxamide
• Synonyms: N-(cyanomethyl)-3-(4-fluorobenzoyl)-N-methyl-2-pyridinecarboxamide
• CAS NO: 168541-96-6
• Molecular Weight: 297.289
• Mol File: 168541-96-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-(cyanomethyl)-3-(4-fluorobenzoyl)-N-methyl-2-pyridinecarboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(cyanomethyl)-3-(4-fluorobenzoyl)-N-methyl-2-pyridinecarboxamide(168541-96-6)
• EPA Substance Registry System: N-(cyanomethyl)-3-(4-fluorobenzoyl)-N-methyl-2-pyridinecarboxamide(168541-96-6)

Safety Data

• Hazardous Substances Data: 168541-96-6(Hazardous Substances Data)

Upstream product

• 462-06-6 fluorobenzene 
• 699-98-9 Pyridine-2,3-dicarboxylic anhydride 
• 25808-30-4 2-(methylamino)acetonitrile hydrochloride 
• 122853-70-7 3-(4-fluorobenzoyl)pyridine-2-carboxylic acid 

Downstream Products

• 168541-93-3 5-(4-fluorophenyl)-7,8-dihydro-7-methyl-8-oxo-6-pyrido<3,4-b>pyridinecarboxylic acid 
• 168541-98-8 5-(4-fluorophenyl)-7,8-dihydro-7-methyl-8-oxo-6-pyrido<3,4-b>pyridinecarboxamide 
• 168541-97-7 5-(4-fluorophenyl)-7,8-dihydro-7-methyl-8-oxo-6-pyrido<3,4-b>pyridinecarbonitrile 

Relevant articles and documents

Heterocyclic compounds, their production and use as tachykinin reactor antagonists

A novel compound represented by the formula: STR1 wherein Ring A and Ring B respectively stands for an optionally substituted homo- or hetero-cyclic ring, and at least one of them stands for an optionally substituted heterocyclic ring stand; Ring C stands for an optionally substituted benzene ring; R stands for a hydrogen atom or an optionally substituted hydrocarbon residue; one of X and Y stands for --NR1 -- (R1 stands for a hydrogen atom or an optionally substituted hydrocarbon residue) or --O--, and the other stands for--CO-- or --CS--, or one of them stands for --N= and the other stands for =CR2 -- (R2 stands for a hydrogen atom, a halogen atom, an optionally substituted hydrocarbon residue, an optionally substituted amino group or an optionally substituted hydroxyl group); n denotes 1 or 2 or salts thereof which have an excellent tachykinin receptor antagonistic action and inhibitory action on plasma extravasation.